Abstract
Background Interventions to minimise community antibiotic use have focused on the GP and patient behaviour rather than the community pharmacist. Patient expectations are a known driver for antibiotic prescribing, and pharmacists may be inveterately contributing to these expectations by referring patients for GPs for suspected antibiotic-requiring infections (S-ARI). We sought to quantify these referral rates.
Method Pharmacists and GPs were recruited independently using convenience sampling and completed prospective data collection on 20 minor ailment encounters and consecutive consultations respectively. Pharmacists recorded patient gender, age, referral reason and comments (if any). GPs recorded patient age, gender, reason for visit, and origin of patient referral including self-referral.
All data were analysed descriptively. Generalised estimating equations, multivariable logistic regression was used to investigate factors that may be associated with pharmacist referral rates.
Results Nineteen pharmacists representing 466 minor ailments encounters, and 19 GPs representing 394 consultations were recruited.
Pharmacists referred 16.5% (77/466) of all minor ailments encounters for S-ARI. Comments suggested that reasons included upper-respiratory tract, ear nose and throat, and urinary tract infections. Most of S-ARI referrals were to a GP (62/466).
None of the 88 consultations for infection in GP data were documented as being referred by a pharmacist; majority were self-referred (77.3%; 68/88).
Discussion Pharmacists referred 1 in 8 minor ailments encounters to the GP for S-ARI, with some indication they were for conditions that do not require antibiotics. Most GP consultations for infection were documented as self-referrals. Both provide potential points of intervention to minimise antibiotic use.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the 2019 Bond University HSM ECR Seed Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Bond University Human Research Ethics Committee gave ethical approval for this work (PS00123)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding This work was supported by the 2019 Bond University HSM ECR Seed Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Declaration of interest statement The author(s) declare that there are no conflicts of interest.
Data availability statement All additional data and analysis code can be accessed via our OSF page (https://osf.io/2yngt/) or by contacting the lead author.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.